Trademark Attorney / Law Firm

Kelly A. Echols – Trademark Portfolio

Kelly A. Echols specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 5 of 5 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 4 other Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending.

5 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Kelly A. Echols's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

31
Natural Agricultural Products (4 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademark applications has Kelly A. Echols filed?

Kelly A. Echols has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 pending, 3 abandoned.

What trademark classes does Kelly A. Echols specialize in?

Kelly A. Echols has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Kelly A. Echols's trademark registration success rate?

Kelly A. Echols has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.